The BioNTech SE ADR BNTX slid 2.69% to $112.51 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and the ...
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the ...
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, "BioNTech” or "the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the ...
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology ...
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. BioNTech exploits a wide array of ...
(MENAFN- GlobeNewsWire - Nasdaq) MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX,“BioNTech” or“the Company”) will present clinical trial data for selected assets from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback